Losartan

Losartan (rINN) (pronounced /loʊˈsɑrtən/) is an angiotensin II receptor antagonist drug used mainly to treat high blood pressure (hypertension). Losartan was the first angiotensin II receptor antagonist to be marketed. It is currently marketed by Merck & Co. under the trade name Cozaar. As with all angiotensin II receptor antagonists, losartan is indicated for the treatment of hypertension. Losartan may also delay progression of diabetic nephropa... more

Also known as:

  • Cozaar

Medicine

ATC Code:

  • C09CA01

Drugbank:

  • APRD00052

Pubchem:

  • 3,961

CAS Number:

  • 114798-26-4
top ↑

Facts from the Community

From the BioVenturist base

Technology involved:

Sales:

Amount Year Area
  • 3,037,200,000
  • 2005
  • 3,163,100,000
  • 2006
  • 3,350,100,000
  • 2007
View entire collection »

Developed by:

Brand Names:

  • Cozaar

Stage of development:

Indication or disease:

Disease Phase of development

Patent Expiration:

  • 2010
top ↑

We can also tell you Losartan is a…

If you know more about Losartan, you can add more facts here »

These people have edited this topic:

Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!

Freebase Attribution

Freebase data is free for use under the CC-BY license.

The original description for Losartan was automatically generated from Wikipedia.org licensed under the GNU Free Documentation License.
[1]
Learn more about Freebase licensing and attribution